| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $363.7M | +19.2% |
| Cost of Revenue | $85.7M | +30.8% |
| R&D Expense | $598.4M | +4.8% |
| SG&A Expense | $461.1M | +33.9% |
| Operating Income | -$878.3M | -23.8% |
| Interest Expense | $84.9M | +3.9% |
| Pre-tax Income | -$910.1M | -21.8% |
| Income Tax | $3.7M | +45.1% |
| Net Income | -$913.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $555.0M | +15.1% |
| Short-term Investments | $878.8M | +194.8% |
| Accounts Receivable | $52.0M | +26.3% |
| Inventory | $98.6M | +18.4% |
| Current Assets | $1.62B | +74.5% |
| Total Assets | $2.03B | +52.3% |
| Current Liabilities | $297.5M | +31.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$683.9M | -27.5% |
| Capital Expenditures | $21.9M | +65.0% |
| Investing Cash Flow | -$583.2M | -160.8% |
| Financing Cash Flow | $1.34B | +696.1% |
| Free Cash Flow | -$705.8M | -28.4% |
| -21.9% |
| EPS (Basic) | -$5.57 | -4.3% |
| EPS (Diluted) | -$5.57 | -4.3% |
| Long-term Debt |
| $1.12B |
| -4.7% |
| Total Liabilities | $1.74B | +4.7% |
| Stockholders' Equity | $285.4M | +186.0% |